JAMA Network

JAMA Ophthalmology : Web-Based Amblyopia Decision Support Tool

13 min · 7. maj 202613 min
episode JAMA Ophthalmology : Web-Based Amblyopia Decision Support Tool cover

Beskrivelse

Interview with Allison I. Summers, OD, MCR, author of Web-Based Amblyopia Decision Support Tool. Hosted by Neil Bressler, MD. Related Content: * Web-Based Amblyopia Decision Support Tool [https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2026.1095?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af JAMA Network-fællesskabet!

Kom i gang

2 måneder kun 19 kr.

Derefter 99 kr. / måned · Opsig når som helst.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts
Kom i gang

Alle episoder

904 episoder

episode JAMA Surgery : Enhanced Recovery Protocol for Children Undergoing Surgery cover

JAMA Surgery : Enhanced Recovery Protocol for Children Undergoing Surgery

Interview with Mehul V. Raval, MD, MS, MBA, and Jane L. Holl, MD, MPH, authors of Implementation and Effectiveness of an Enhanced Recovery Protocol for Children Undergoing Surgery: The ENRICH-US Stepped-Wedge Cluster-Randomized Trial. Hosted by Jamie Coleman, MD. Related Content: * Implementation and Effectiveness of an Enhanced Recovery Protocol for Children Undergoing Surgery [https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2026.1382?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * Multicomponent Enhanced Recovery After Surgery—Implementation Affects Effectiveness [https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2026.1381?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

13. maj 202614 min
episode JAMA Internal Medicine : Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism cover

JAMA Internal Medicine : Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism

Interview with Shalender Bhasin, MBBS, author of Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial, and Peter C. Albertsen, MD, author of Collaborating to Improve Quality of Life Among Prostate Cancer Survivors. Hosted by Eve Rittenberg, MD. Related Content: * Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.1343?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * Collaborating to Improve Quality of Life Among Prostate Cancer Survivors [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.1357?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

11. maj 202613 min
episode JAMA Internal Medicine : Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease cover

JAMA Internal Medicine : Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease

Interview with Vineet Ahuja, DM, author of Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease: A Randomized Trial and Michael H. Woodworth, MD, MSc, author of Fecal Microbiota Transplant for Multidrug Resistance—No Benefit Without Disruption? Hosted by Ilana Richman, MD, MHS. Related Content: * Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.0655?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * Fecal Microbiota Transplant for Multidrug Resistance—No Benefit Without Disruption? [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.0668?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

20. apr. 202614 min